StonvexLoading…
StonvexStonvexStonvexCore line items from INVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $21.48M | $26.63M | $43.45M | $112.92M |
Operating Income | $-22.15M | $-27.96M | $-13.51M | $-333.00K |
Net Income | $-18.00M | $74.82M | $-5.49M | $-392.00B |
EPS (Diluted) | $-0.79 | $3.14 | $-0.29 | $-0.07 |
Total Assets | $151.34M | $163.22M | $109.72M | $102.77M |
Total Liabilities | $10.64M | $9.16M | $35.45M | $27.37M |
Cash & Equivalents | $128.61M | $135.65M | $23.31M | $16.65M |
Free Cash Flow OCF − CapEx | $-7.81M | $-16.93M | $-3.13M | $-11.71M |
Shares Outstanding | 23.77M | 23.43M | 23.25M | 22.62M |